ARB-type antihypertensives in the down-turning market

Published: 2016-02-01 14:15:43

Updated: 2016-02-01 14:15:43

The Big 4 ARB-type antihypertensives – Twynsta(Boehringer Ingelheim), Amosartan(Hanmi Pharm), Exforge(Novartis) and Sevikar(Daiichi Sankyo) – have shown decreases altogether.

According to the UBIST data on the 28^th, the highest prescribed ARB-type antihypertensive was Twynsta recording KRW 84.4 billion prescriptions, yet decreased by 5.6% year-on-year.

The second highest was Amosartan taking ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.